Abstract:Replacement of diseased organs with transplanted healthy donor ones remains the best and often only treatment option for end-stage organ disease. Immunosuppressants have decreased the incidence of acute rejection, but long-term survival remains limited. The broad action of current immunosuppressive drugs results in global immune impairment, increasing the risk of cancer and infections. Hence, achievement of allograft tolerance, in which graft function is maintained in the absence of global immunosuppression, has long been the aim of transplant clinicians and scientists. Regulatory T cells (Treg) are a specialized subset of immune cells that control a diverse array of immune responses, can prevent allograft rejection in animals, and have recently been explored in early phase clinical trials as an adoptive cellular therapy in transplant recipients. It has been established that allograft residency by Tregs can promote graft acceptance, but whether intragraft Treg functional diversification and spatial organization contribute to this process is largely unknown. In this review, we will explore what is known regarding the properties of intragraft Tregs during allograft acceptance and rejection. We will summarize recent advances in understanding Treg tissue residency through spatial, transcriptomic and high-dimensional cytometric methods in both animal and human studies. Our discussion will explore properties of intragraft Tregs in mediating operational tolerance to commonly transplanted solid organs. Finally, given recent developments in Treg cellular therapy, we will review emerging knowledge of whether and how these adoptively transferred cells enter allografts in humans. An understanding of the properties of intragraft Tregs will help lay the foundation for future therapies that will promote immune tolerance.

Innate immunity: Trained immunity and innate allorecognition against the allograft

Innate allorecognition by monocytic cells and its role in graft rejection

Innate and Adaptive Immune Responses in Intestinal Transplant Rejection: Through the Lens of Inflammatory Bowel and Intestinal Graft-Versus-Host Diseases

Innate immune modulation in transplantation: mechanisms, challenges, and opportunities

Activation of immune signals during organ transplantation

Trained immunity in organ transplantation

Innate Immune Cells in Transplantation

Activation and regulation of alloreactive T cell immunity in solid organ transplantation

Mechanisms of Immunological Rejection in Transplantation

Intestinal transplantation: Significance of immune responses

The Immunological Basis of Liver Allograft Rejection

Immune rejection: current understanding and new solutions

The innate NK cells, allograft rejection, and a key role for IL-15

The Innate Cellular Immune Response in Xenotransplantation

Innate Cellular Immunity and Xenotransplantation.

Emerging strategies to bypass transplant rejection via biomaterial-assisted immunoengineering: Insights from islets and beyond

Intragraft regulatory T cells in the modern era: what can high-dimensional methods tell us about pathways to allograft acceptance?

Adoptive Transfer of Regulatory Immune Cells in Organ Transplantation

Advances in Innate Immunity to Overcome Immune Rejection during Xenotransplantation

Toll-like receptors and graft rejection.

Immune landscape of the kidney allograft in response to rejection